Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery

Edwin C McGee Jr; Umraan Ahmad; Daniel Tamez; Michael Brown; Neil Voskoboynikov; Sukit Chris Malaisrie; Richard Lee; Patrick M McCarthy

doi:10.1016/j.athoracsur.2011.02.081

Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery

Ann Thorac Surg. 2011 Jul;92(1):e1-3. doi: 10.1016/j.athoracsur.2011.02.081.

Authors

Edwin C McGee Jr¹, Umraan Ahmad, Daniel Tamez, Michael Brown, Neil Voskoboynikov, Sukit Chris Malaisrie, Richard Lee, Patrick M McCarthy

Affiliation

¹ Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611-2968, USA. [email protected]

PMID: 21718817
DOI: 10.1016/j.athoracsur.2011.02.081

Abstract

HeartWare continuous flow ventricular assist devices (HVAD) configured as biventricular assist devices maintain diurnal flow variation, lead to end-organ recovery, and provide for a successful bridge-to-heart transplantation in the first successful North American use of continuous flow biventricular assist devices.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Critical Illness
Emergency Treatment / methods
Equipment Design
Equipment Safety
Follow-Up Studies
Heart Transplantation / methods*
Heart-Assist Devices*
Humans
Male
Risk Assessment
Shock, Cardiogenic / diagnosis*
Shock, Cardiogenic / surgery*
Time Factors
Treatment Outcome
Ventricular Remodeling / physiology*
Waiting Lists